Company: MDCXW
Filing Date: 2025-06-13
Form Type: PRE 14A
Source: 0001062993-25-011673
Chunk: 9

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-13
Form: PRE 14A
Chunk 9
---
 the transaction of business at the Meeting.

What vote is required to approve each item?

| Proposal                                                                                                  |     | Required Vote                                                    |
| Appointment and remuneration of the auditors                                                              |     | Majority of the votes cast on the proposal                       |
| The election of directors                                                                                 |     | Majority of the votes cast on the proposal                       |
| The amendment of the Company's By-Law No. 1                                                               |     | Majority of the votes cast on the proposal                       |
| Approval of the issuance of Common Shares pursuant to the SEPA in accordance with the Nasdaq 20% Rule     |     | Majority of the votes cast on the proposal                       |
| A special resolution authorizing the Board to approve a consolidation or share split of the Common Shares |     | More than two-thirds (66 2⁄3%) of the votes cast on the proposal |
| The amendment of the Articles of Incorporation of the Company (the "Articles")                            |     | More than two-thirds (66 2⁄3%) of the votes cast on the proposal |

If you indicate "WITHHOLD" in respect to the election of directors, your vote will be counted for purposes of determining the presence or absence of a quorum for the transaction of business at the Meeting. As described below under "", broker non-votes will be counted for determining the presence or absence of a quorum for the transaction of business at the Meeting, but will not be considered votes cast with respect to the election of any director nominee or on any other proposal.

What happens if additional items are presented at the Meeting?

As of the date of this proxy statement, management of the Company knows of no such amendments, variations or other matters to come before the Meeting. However, if other matters properly come before the Meeting, it is the intention of the persons named in the enclosed Proxy Card to vote such proxy according to their best judgment.

Where can I find the voting results?

We expect to announce preliminary voting results at the Meeting and to publish final results in a current report on Form 8-K that we will file with the SEC and in a report of voting results in accordance with National Instrument 51-102 - Continuous Disclosure Obligations ("NI 52-102"); that we will file in Canada on SEDAR+ promptly following the Meeting. Both the Form 8-K and report on voting results will also be available on the "Investor Relations" section of our website at www.medicuspharma.com/investor-relations.